[ad_1]
Both sources said the timeline is based on expectations that Pfizer, which created the vaccine in cooperation with Germany’s Biontech, will have enough data from clinical trials to seek approval for use of the vaccine. emergency for this age group with the United States Food and Drug Administration. by the end of this month.
Depending on their expectations, the administration can make a decision on the safety and efficacy of the vaccine for children within 3 weeks of filing the application.
Millions of Americans await decision to approve immunizations for children, especially parents whose children have started school in recent weeks, amid a wave of infections caused by the spread of the strain Corona virus delta.
[ad_2]
Source link
